drugset / Trial / NCT04860804

A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain

NCT04860804 ↗

Phase 4 Completed 60 enrolled Antonios Likourezos
RandomizedParallel-groupOpen-labelTreatment

Summary

Acute Pain is one of the most frequent chief complaints and the main reason for visiting the Emergency Department (ED). The acute pain in the ED is largely prevalent across the country with recent literature demonstrating that 61-91% of patients are admitted to the ED due to a variety of acute painful syndromes. There is a lack of good options for pain control in such settings.

Timeline

Start
2021-04-22
Primary completion
2021-11-30
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 324 mg Oral
Comparator Ketamine Small molecule 0.5 mg/kg Oral

Indications

No indication recorded.